Clinical Trial Update: Biomarkers for the Prognosis of Decompensated Alcoholic Liver Disease

View source ↗

Summary

A completed University of Nottingham clinical trial investigated biomarkers to predict prognosis in decompensated alcoholic liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Liver Disease
• Decompensated Cirrhosis

Snippet

Sponsor: University of Nottingham | Conditions: Alcoholic Liver Diseases, Decompensated Cirrhosis | Status: COMPLETED